Covered recipient · General Payments record
CRAIG L REITZ
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$1,250.39
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $134.55 | 12 |
| Food and Beverage | $117.69 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $134.55 | 12 |
| E.R. Squibb & Sons, L.L.C. | $56.65 | 3 |
| ABBVIE INC. | $31.34 | 2 |
| Astellas Pharma US Inc | $15.01 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $14.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.99 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105936806 | CMS |
| ABBVIE INC. | $15.35 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105936808 | CMS |
| Astellas Pharma US Inc | $15.01 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139321960 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.10 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101311835 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.27 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101311847 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.28 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101311871 | CMS |
| PFIZER INC. | $16.01 | 02/05/2024 | Education | Undisputed | 01/23/2026 | 1131589016 | CMS |
| PFIZER INC. | $9.76 | 02/05/2024 | Education | Undisputed | 01/23/2026 | 1132055622 | CMS |
| PFIZER INC. | $11.88 | 02/05/2024 | Education | Undisputed | 01/23/2026 | 1132056234 | CMS |
| PFIZER INC. | $11.88 | 04/17/2024 | Education | Undisputed | 01/23/2026 | 1132058014 | CMS |
| PFIZER INC. | $9.66 | 04/17/2024 | Education | Undisputed | 01/23/2026 | 1132067453 | CMS |
| PFIZER INC. | $11.88 | 07/10/2024 | Education | Undisputed | 01/23/2026 | 1132058158 | CMS |
| PFIZER INC. | $11.88 | 07/11/2024 | Education | Undisputed | 01/23/2026 | 1132060250 | CMS |
| PFIZER INC. | $11.88 | 07/13/2024 | Education | Undisputed | 01/23/2026 | 1132059316 | CMS |
| PFIZER INC. | $7.98 | 08/22/2024 | Education | Undisputed | 01/23/2026 | 1132059718 | CMS |
| PFIZER INC. | $11.88 | 08/22/2024 | Education | Undisputed | 01/23/2026 | 1132060616 | CMS |
| PFIZER INC. | $7.98 | 09/27/2024 | Education | Undisputed | 01/23/2026 | 1132067265 | CMS |
| PFIZER INC. | $11.88 | 09/27/2024 | Education | Undisputed | 01/23/2026 | 1132067561 | CMS |
| PUMA BIOTECHNOLOGY, INC. | $14.69 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113859051 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.